Peripheral-Type Benzodiazepine Receptor (TSPO) Peptid
TSPO
Reaktivität: Human
Wirt: Synthetic
BP, BI
Produktnummer ABIN5686068
Kurzübersicht für Peripheral-Type Benzodiazepine Receptor (TSPO) Peptid (ABIN5686068)
Target
TSPO
(Peripheral-Type Benzodiazepine Receptor (TSPO))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), BioImaging (BI)
-
-
Produktmerkmale
- TSPO peptide corresponds to 14 amino acids of TSPO.
-
-
-
-
Applikationshinweise
- TSPO Peptide is used for blocking the activity of TSPO antibody . The TSPO antibody ships at 0.5 mg/mL and the TSPO Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- TSPO peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
Sie sind hier:
